RA Kyle

1.3k total citations
17 papers, 826 citations indexed

About

RA Kyle is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, RA Kyle has authored 17 papers receiving a total of 826 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hematology, 5 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in RA Kyle's work include Multiple Myeloma Research and Treatments (12 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (4 papers) and Cancer Treatment and Pharmacology (3 papers). RA Kyle is often cited by papers focused on Multiple Myeloma Research and Treatments (12 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (4 papers) and Cancer Treatment and Pharmacology (3 papers). RA Kyle collaborates with scholars based in United States, Australia and Canada. RA Kyle's co-authors include W. Michael O’Fallon, PR Greipp, JA Katzmann, JA Lust, TE Witzig, Angela Dispenzieri, J B Seward, Patricia A. Pellikka, MA Gertz and MQ Lacy and has published in prestigious journals such as JAMA, Blood and European Heart Journal.

In The Last Decade

RA Kyle

14 papers receiving 809 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
RA Kyle United States	12	542	540	297	163	73	17	826
Cindy Varga United States	17	519 1.0×	371 0.7×	266 0.9×	170 1.0×	89 1.2×	60	746
Lian X. Tang United Kingdom	4	511 0.9×	451 0.8×	187 0.6×	170 1.0×	46 0.6×	6	748
Eurydiki Michalis Greece	13	429 0.8×	516 1.0×	341 1.1×	284 1.7×	58 0.8×	24	858
Paola Masolini Italy	17	252 0.5×	389 0.7×	294 1.0×	187 1.1×	29 0.4×	24	849
Zdeněk Adam Czechia	14	482 0.9×	522 1.0×	298 1.0×	100 0.6×	20 0.3×	156	929
Naresh Bumma United States	10	290 0.5×	226 0.4×	266 0.9×	102 0.6×	64 0.9×	70	557
Alfonso García de Coca Spain	16	552 1.0×	657 1.2×	309 1.0×	346 2.1×	20 0.3×	47	984
Miguel‐Teodoro Hernández Spain	14	597 1.1×	796 1.5×	544 1.8×	210 1.3×	18 0.2×	44	1.2k
S. Naucke United States	8	931 1.7×	1.4k 2.5×	674 2.3×	198 1.2×	13 0.2×	10	1.5k
Tong Sun United States	9	367 0.7×	195 0.4×	109 0.4×	148 0.9×	30 0.4×	22	704

Countries citing papers authored by RA Kyle

Since Specialization

Citations

This map shows the geographic impact of RA Kyle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by RA Kyle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites RA Kyle more than expected).

Fields of papers citing papers by RA Kyle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by RA Kyle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by RA Kyle. The network helps show where RA Kyle may publish in the future.

Co-authorship network of co-authors of RA Kyle

This figure shows the co-authorship network connecting the top 25 collaborators of RA Kyle. A scholar is included among the top collaborators of RA Kyle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with RA Kyle. RA Kyle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Kyle, RA. (2021). Pathophysiology of Trauma. PubMed. 58(7). 511–3.

Freytes, César O., David H. Vesole, Xiaobo Zhong, et al.. (2013). Second transplants for multiple myeloma relapsing after a previous autotransplant—reduced-intensity allogeneic vs autologous transplantation. Bone Marrow Transplantation. 49(3). 416–421. 38 indexed citations

Kapoor, Prashant, RA Kyle, S. Vincent Rajkumar, et al.. (2009). A366 Relevance of Conventional Prognostic Factors in Multiple Myeloma (MM) in the Era of Novel Therapies. Clinical Lymphoma & Myeloma. 9. S60–S60.

Gertz, MA, MQ Lacy, Angela Dispenzieri, et al.. (2009). A481 Long-Term Results of Single-Agent Thalidomide as Initial Therapy for Smoldering or Indolent Myeloma. Clinical Lymphoma & Myeloma. 9. S76–S77. 1 indexed citations

Modesto, Karen, Angela Dispenzieri, MA Gertz, et al.. (2007). Vascular abnormalities in primary amyloidosis. European Heart Journal. 28(8). 1019–1024. 47 indexed citations

Kyle, RA. (1999). High-dose therapy in multiple myeloma and primary amyloidosis: an overview.. PubMed. 26(1). 74–83. 17 indexed citations

Kyle, RA. (1999). Clinical aspects of multiple myeloma and related disorders including amyloidosis.. PubMed. 47(2). 148–57. 16 indexed citations

Lacy, MQ, et al.. (1998). Contrast in cytokine expression between patients with monoclonal gammopathy of undetermined significance or multiple myeloma. Leukemia. 12(4). 593–600. 30 indexed citations

Kay, NE, MM Oken, RA Kyle, et al.. (1995). Circulating CD19+ blood cell levels in myeloma. ECOG Myeloma Clinical Trials Laboratory Study Group [letter]. Blood. 86(10). 4000–4001. 13 indexed citations

10.

Kyle, RA. (1994). Monoclonal gammopathy of undetermined significance. Blood Reviews. 8(3). 135–141. 48 indexed citations

11.

Kyle, RA. (1994). Why better prognostic factors for multiple myeloma are needed [editorial] [see comments]. Blood. 83(7). 1713–1716. 49 indexed citations

12.

Greipp, PR, JA Lust, W. Michael O’Fallon, et al.. (1993). Plasma cell labeling index and beta 2-microglobulin predict survival independent of thymidine kinase and C-reactive protein in multiple myeloma [see comments]. Blood. 81(12). 3382–3387. 241 indexed citations

13.

Kyle, RA. (1990). Newer approaches to the therapy of multiple myeloma [editorial]. Blood. 76(9). 1678–1679. 15 indexed citations

14.

Greipp, PR, JA Katzmann, W. Michael O’Fallon, & RA Kyle. (1988). Value of beta 2-microglobulin level and plasma cell labeling indices as prognostic factors in patients with newly diagnosed myeloma. Blood. 72(1). 219–223. 142 indexed citations

15.

Kyle, RA, PR Greipp, & W. Michael O’Fallon. (1986). Primary systemic amyloidosis: multivariate analysis for prognostic factors in 168 cases. Blood. 68(1). 220–224. 164 indexed citations

16.

Kyle, RA, et al.. (1985). Serum antibody to respiratory syncytial virus in goats in the UK. Veterinary Record. 116(9). 239–240. 1 indexed citations

17.

Kyle, RA. (1979). Carl Peter Thunberg. JAMA. 242(18). 2008–2008. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact